CN113004216A - Preparation method and application of novel benzoxazine hypochlorous acid fluorescent molecular probe - Google Patents
Preparation method and application of novel benzoxazine hypochlorous acid fluorescent molecular probe Download PDFInfo
- Publication number
- CN113004216A CN113004216A CN201911322539.8A CN201911322539A CN113004216A CN 113004216 A CN113004216 A CN 113004216A CN 201911322539 A CN201911322539 A CN 201911322539A CN 113004216 A CN113004216 A CN 113004216A
- Authority
- CN
- China
- Prior art keywords
- solution
- reaction
- detection
- hypochlorous acid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003068 molecular probe Substances 0.000 title claims abstract description 20
- -1 benzoxazine hypochlorous acid Chemical compound 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 41
- 239000000243 solution Substances 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 239000007850 fluorescent dye Substances 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 17
- 229920006395 saturated elastomer Polymers 0.000 claims description 16
- 239000012044 organic layer Substances 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000004440 column chromatography Methods 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 239000012264 purified product Substances 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 3
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 claims description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 3
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000002189 fluorescence spectrum Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N CHCl3 Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 230000005284 excitation Effects 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 230000003013 cytotoxicity Effects 0.000 abstract description 2
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 8
- 230000004044 response Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical compound BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000003896 Myeloperoxidases Human genes 0.000 description 2
- 108090000235 Myeloperoxidases Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RWSXRVCMGQZWBV-PHDIDXHHSA-N L-Glutathione Natural products OC(=O)[C@H](N)CCC(=O)N[C@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-PHDIDXHHSA-N 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0028—Oxazine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a preparation method and application of a novel benzoxazine hypochlorous acid fluorescent molecular probe, wherein the chemical structural formula of the benzoxazine hypochlorous acid fluorescent molecular probe is as follows:
Description
Technical Field
The invention belongs to the technical field of analytical chemistry, and relates to a preparation method and application of a novel benzoxazine hypochlorous acid fluorescent molecular probe.
Background
Hypochlorous acid (HOCl), which is catalytically produced from hydrogen peroxide and chloride ions by Myeloperoxidase (MPO), is an important member of the active oxygen family in vivo and plays an important role in physiological and pathological processes. HOCl is strongly oxidative, killing pathogens, thus contributing to host defense, and endogenous HClO can also serve as a signal to activate caspases and mediate apoptosis. However, excessive amounts of HClO in the body can cause oxidative damage to biomolecules such as nucleic acids, proteins and lipids, which can lead to various diseases such as cardiovascular disease, atherosclerosis, osteoarthritis, rheumatoid arthritis and lung injury. Therefore, monitoring the concentration level of HClO in cells is of great importance to further understand its biological role and to diagnose related diseases early.
In recent years, electrochemical, colorimetric, chemiluminescent, and fluorescence imaging methods have been used for detecting HClO. Among them, the fluorescence imaging method is widely used in detection and imaging of HClO due to its advantages of high sensitivity, strong specificity, short response time, real-time monitoring, etc. CN 110357869A reports a fluorescent molecular probe based on a naphthalimide mother nucleus and capable of being used for HClO specific detection, and the fluorescent molecular probe has good chemical and light stability. However, after the probe responds to HClO, the fluorescence at 510 nm gradually weakens, and the probe presents a 'Turn-OFF' type fluorescence response, is easily influenced by environment and has larger detection error. CN 109400563A reported a fluorescent probe CoPh-ClO that achieved rapid detection of HClO specificity, which could be used as a specific indicator of the presence of HClO in aqueous solutions and in biological cells. However, the probe has the problem of short emission wavelength (-510 nm) and is easily interfered by background fluorescence when in intracellular imaging. CN 109942504A reports that HClO response probe molecules are constructed by using near-infrared fluorophore basic blue as a fluorescent molecular framework, fluorescence turn-on is realized by using the conversion of a reduction state and an oxidation state, and when HClO is added, the probe shows fluorescence enhancement at 670 nm, so that HClO detection can be realized. However, the probe has poor water solubility, so that the biocompatibility is poor, and the further application of the probe in detecting HClO in organisms is limited. Therefore, the development of a red light emitting fluorescent molecular probe with high sensitivity, high specificity and good water solubility has very important significance for realizing the detection of HClO in environment and organisms.
Disclosure of Invention
Aiming at the defects of the existing HClO fluorescent molecular probe, the invention aims to provide the HClO fluorescent molecular probe which has good water solubility, high specificity and red light emission.
The second purpose of the invention is to provide a high-efficiency preparation method of the fluorescent molecular probe.
The third purpose of the invention is to provide the application of the fluorescent molecular probe in the detection of HClO in aqueous solution and organisms.
In order to achieve the above object, the present invention provides a fluorescent molecular probe having a structure of formula I:
formula I
The preparation method of the fluorescent probe is preferably as follows:
dissolving benzoxazine in anhydrous DMF solution, 0oAdding 60% NaH solution and p-bromobenzyl bromide in batches at the temperature of C, stirring at room temperature to react, and cooling to 0oC, dropwise adding water to quench the reaction, and respectively using water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product. Dissolving the purified product in CHCl3The solution was added NBS in portions and the reaction was stirred at room temperature to completion. Taking off the reaction, adding water dropwise to quench the reaction, and respectively using water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and recrystallizing with ethyl acetate to obtain white solid. The purified product, 4-nitrophenol, potassium acetate and Pd (dppf) Cl2DCM was dissolved in anhydrous DMF solution and heated under reflux under argon to completion. The reaction was cooled to room temperature, and then water and saturated NaHCO were added to the reaction mixture3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product. The purified product and SnCl2·2H2O addition to CH3OH, concentrated HCl and H2Stirring the mixture at room temperature until the reaction is completed, and adding saturated Na2CO3Adjusting pH of the solution to alkaline, and respectively adding water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain the target molecular probe.
The synthesis of the invention is as follows:
the invention provides application of the fluorescent probe, which can be applied to detection of HClO. The detection mechanism of the probe is shown as the following figure:
compared with the prior art, the technical scheme of the invention has the beneficial technical effects that:
the fluorescent molecular probe for detecting HClO has the following advantages:
(1) the fluorescent probe has the advantages of stable and high chemical property and optical stability, and has no autoxidation and no photobleaching phenomenon;
(2) the fluorescent probe has the advantages of good water solubility, quick response and high specificity, can avoid the interference of other objects to be detected, is favorable for quickly detecting HClO in the environment, and has stronger practical application value in the field of environmental science;
(3) the probe has stronger red light emission, can effectively avoid the interference of biological autofluorescence, has good cell membrane permeability and low cytotoxicity, can be used for biological imaging of HClO, and has stronger practical application value in the field of life science.
Drawings
FIG. 1 is a graph showing the emission spectrum of the fluorescence intensity of the fluorescent probe varying with the HClO concentration in the practice of the present invention;
FIG. 2 is a graph showing the selectivity of fluorescent probes for HClO in the practice of the present invention;
FIG. 3 is a confocal image of fluorescence of fluorescent probe in HeLa cell in the practice of the present invention.
Detailed Description
The following embodiments are intended to further illustrate the present invention and are not intended to limit the present invention.
Example 1
Synthesis of Compound 1:
benzoxazine (1830 mg, 10 mmol) was dissolved in 25 mL anhydrous DMF at 0oC, adding 60% NaH solution (4727 mg, 12 mmol) in portions, stirring for 10 minutes, adding p-bromobenzyl bromide (3000 mg, 12 mmol) in portions, and stirring at room temperature until the reaction is finished. Cooling to 0 deg.C after reaction, adding water dropwise to quench the reaction, and adding water and saturated NaHCO respectively3Extracting the solution with saturated saline solution, combining organic layers, drying with anhydrous magnesium sulfate, concentrating, and purifying by column chromatography to obtain 2899 mg of white product with the yield of 82.3%.
Synthesis of Compound 2:
compound 1 (2817.6 mg, 8 mmol) was dissolved in 25 mL HCl3To the solution, NBS (2854.6 mg, 9.08 mmol) was added in portions, and the reaction was stirred at room temperature until completion. Taking off the reaction, adding water dropwise to quench the reaction, and respectively using water and saturated NaHCO3The solution and saturated brine were extracted, the organic layers were combined, dried over anhydrous magnesium sulfate, concentrated and dried to give a crude product, which was recrystallized from ethyl acetate to give 2044.1 mg of a white solid with a yield of 50.1%.
Synthesis of Compound 3:
compound 2 (2040 mg, 4 mmol), 4-nitrophenol (2225.6 mg, 16 mmol), potassium acetate (2348.7 mg, 24 mmol) and Pd (dppf) Cl2DCM (2817.7 mg, 0.4 mmol) was dissolved in 7 mL of anhydrous DMF and heated under reflux under argon to completion. The reaction was cooled to room temperature, and then water and saturated NaHCO were added to the reaction mixture3Extracting the solution with saturated saline, combining organic layers, drying with anhydrous magnesium sulfate, concentrating, drying, and purifying by column chromatography to obtain white product 1128.2 mg with yield 41.2%.1H NMR (300 MHz, CDCl3) δ 8.82 (d, 6H, J=7.8 Hz), 7.43 (d, 2H, J=8.3 Hz), 7.28 (d, 2H, J=8.3 Hz), 7.21 (d, 6H, J=7.8 Hz), 6.66 (s, 2 H), 6.52-6.51(m, 4H), 4.32 (s, 2H)。
Synthesis of target molecular probe:
to compound 3 (684.6 mg, 1 mmol) and SnCl2·2H2O (3371.4 mg, 15 mmol) was added to 16 mL CH3OH: concentrated HCl: h2A mixed solution of O =3:2:3 was stirred at room temperature until the reaction was completed. After the reaction is finished, saturated Na is used2CO3Adjusting pH of the solution to alkaline, and respectively adding water and saturated NaHCO3The solution was extracted with saturated brine, and the organic layers were combined, dried over anhydrous magnesium sulfate, concentrated and dried. After column chromatography purification, 319.3 mg of the target molecular probe is obtained, and the yield is 53.7%.1H NMR (300 MHz, CDCl3) δ 7.35 (d, 2H, J=8.4 Hz), 7.30 (d, 2H, J=8.4 Hz), 7.21 (d, 6H, J=7.8 Hz), 6.76-6.73 (m, 12H), 6.65 (s, 2H), 6.53-6.50 (m, 4H), 6.27 (s, 6H), 4.30 (s, 2 H)。HRMS (ESI): calculated [M+H]+: 595.22670, found [M+H]+: 595.21371。
Example 2
Preparation of fluorescent probe mother liquor
The product isolated above and having a purity of 99% is accurately weighed at 5.94 mg and carefully transferred into a 50 mL volumetric flask, into which CH is added at room temperature3CN solution is dissolved completely, and the volume is determined to the scale mark, thus obtaining the probe mother liquor with the concentration of 1 mM. During the test, 20. mu.L of the above solution was taken out by a micro-injector each time, and dissolved in the test system so that the total volume per test was 2 mL, at which time the concentration of the fluorescent probe was 10. mu.M.
Example 3
Preparation of HClO mother liquor
HClO was prepared as 5 mL stock solutions in different concentration gradients (0.1 mM, 0.3 mM, 0.6 mM, 1.0 mM, 1.5 mM, 2.0 mM, 3.0 mM, 4.0 mM) in PBS buffer. The other substances to be tested required by the test are respectively prepared into mother liquor with the concentration of 3 mM by using PBS buffer solution.
Example 4
Relationship between fluorescence intensity of fluorescent probe and HClO concentration
4.900 mL of PBS buffer solution was measured, 50. mu.L of 1 mM probe stock solution was dissolved therein, and 50. mu.L of different HClO stock solutions were transferred so that the concentration of the probe in the entire detection system was 10. mu.M and Hg was finally obtained2+The concentrations of (A) were 1. mu.M, 3. mu.M, 6. mu.M, 10. mu.M, 15. mu.M, 20. mu.M, 30. mu.M and 40. mu.M, respectively. After incubation at room temperature for 20 min, the fluorescence spectra of the different systems were tested in 10 mm cuvettes, respectively (FIG. 1). The results show that the fluorescence emission intensity of the system at 590 nm is gradually increased with the gradual increase of the HClO concentration.
Example 5
Selectivity of fluorescent probes for HClO detection
The concentration of the probe master is 1 mMmu.L of the solution was dissolved in 4.900 mL of PBS buffer solution, and 50. mu.L of 3 mM O was transferred2-、NO、H2O2Tert-butyl peroxy alcohol, NO3-, L-cysteine, L-glutathione, Fe3+The mother solutions were added to the system, incubated at room temperature for 20 min, the fluorescence spectra were measured, and the fluorescence intensity at 590 nm was recorded (FIG. 2). As shown in the figure, the results show that the fluorescence of the fluorescent probe is obviously enhanced only by adding HClO, and no or only weak fluorescence change is generated when other test metal ions or molecules are added. The fluorescent probe is shown to have good selectivity.
Example 6
Response of fluorescent probes to HClO in cells
Adding 10 μ M fluorescent probe solution into HeLa medium, and placing at 37oC, 5% CO2After incubation in the incubator for 30 minutes, the cells were washed three times with 0.1M PBS buffer (10 mM, pH = 7.4) to remove probe molecules that have not entered the cells, the medium was then replaced, the cells were incubated with hcl buffer solution (25 μ M) for 30 minutes, washed three times with 0.1M PBS buffer (10 mM, pH = 7.4), and the change in fluorescence was observed under a fluorescence microscope, as shown in fig. 3. Experiments show that the probe molecules entering the cell body react with HClO to emit strong red fluorescence, so that the fluorescent probe has a good imaging effect on HClO in the cell and can be used for detecting HClO in the organism.
Although the present invention has been described with reference to the specific embodiments shown in the drawings, it is not intended to limit the scope of the present invention, and various modifications or variations can be made by those skilled in the art from the disclosure of the present invention without inventive efforts.
Claims (5)
2. The method for preparing the novel fluorescent probe for hypochlorous acid detection according to claim 1, wherein the method comprises the following steps: dissolving benzoxazine in anhydrous DMF solution, 0oAdding 60% NaH solution and benzyl bromide 4-BnBr in batches at the temperature of C, stirring at room temperature to react, cooling to 0oC, dropwise adding water to quench the reaction, and respectively using water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product;
dissolving the purified product in CHCl3Adding NBS into the solution in batches, and stirring and reacting at room temperature until the reaction is finished;
taking off the reaction, adding water dropwise to quench the reaction, and respectively using water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and recrystallizing with ethyl acetate to obtain white solid;
the purified product, 4-nitrophenol, potassium acetate and Pd (dppf) Cl2DCM was dissolved in anhydrous DMF solution and heated under reflux under argon protection until the reaction was complete;
the reaction was cooled to room temperature, and then water and saturated NaHCO were added to the reaction mixture3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product;
the purified product and SnCl2·2H2O addition to CH3OH, concentrated HCl and H2Stirring the mixture at room temperature until the reaction is completed, and adding saturated Na2CO3Adjusting pH of the solution to alkaline, and respectively adding water and saturated NaHCO3Extracting the solution with saturated saline water, and respectively extracting with water and saturated NaHCO3Extracting the solution with saturated saline solution, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain the target molecular probe.
3. Use of the fluorescent probes according to claims 1 and 2 for the detection of HOCl in the environment and in cells.
4. Use of a fluorescent probe according to any of claims 1-3, characterized in that the detection conditions in the environment and the cells are: the excitation wavelength is 365 nm, the fluorescence emission spectrum detection is carried out between 400-700 nm, the solvent of the detection system is PBS (10 mM, pH = 7.4) buffer solution, and the pH is 5.8-8.4.
5. The use according to claims 1 to 4, wherein the solution to be tested is added to the fluorescent probe detection solution, and the fluorescence intensity of the detection solution is measured as an evaluation index for the presence or absence of hypochlorous acid and the quantitative determination of hypochlorous acid concentration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322539.8A CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322539.8A CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113004216A true CN113004216A (en) | 2021-06-22 |
CN113004216B CN113004216B (en) | 2023-10-03 |
Family
ID=76381740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911322539.8A Active CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113004216B (en) |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100081159A1 (en) * | 2008-09-26 | 2010-04-01 | Lebedeva Irina V | Profiling reactive oxygen, nitrogen and halogen species |
CN102382641A (en) * | 2011-09-22 | 2012-03-21 | 厦门大学 | Fluorescent probe for detecting hypochlorous acid and preparation method thereof |
CN103709122A (en) * | 2013-11-29 | 2014-04-09 | 四川大学 | Antitumor and antifungal compound for treatment |
US20160047816A1 (en) * | 2014-07-25 | 2016-02-18 | SeLux Diagnostics, Inc. | Assay methods involving dissociable nanoparticles |
CN105622632A (en) * | 2014-10-29 | 2016-06-01 | 浙江海森药业有限公司 | Quinolones compound and preparation method thereof |
CN108148055A (en) * | 2018-02-06 | 2018-06-12 | 陕西师范大学 | A kind of D- π-A types organic fluorescence materials and preparation method based on naphthalene |
CN108864350A (en) * | 2018-08-20 | 2018-11-23 | 武汉华星光电半导体显示技术有限公司 | Thermal activation delayed fluorescence material, synthetic method, OLED luminescent device, display device |
CN109384719A (en) * | 2017-08-10 | 2019-02-26 | 湖南超亟化学科技有限公司 | A kind of preparation and application detecting formaldehyde fluorescent molecular probe, synthetic method and test paper |
CN109593192A (en) * | 2018-12-05 | 2019-04-09 | 中国科学院长春应用化学研究所 | Polyarylether/poly arylidene thio-ester and its preparation method and application with thermal activation delayed fluorescence effect |
CN109942504A (en) * | 2019-03-25 | 2019-06-28 | 浙江师范大学 | It is a kind of to detect hypochlorous fluorescent probe molecule and preparation method thereof |
CN113200935A (en) * | 2021-04-26 | 2021-08-03 | 威海海洋生物医药产业技术研究院有限公司 | Fluorescent probe for hypochlorous acid detection and preparation method thereof |
CN113493564A (en) * | 2020-04-07 | 2021-10-12 | 中国科学院长春应用化学研究所 | Organic polymer luminescent material with D-sigma-A structure and preparation method and application thereof |
WO2021261398A1 (en) * | 2020-06-25 | 2021-12-30 | コニカミノルタ株式会社 | Light-emitting nanoparticles and light-emitting labeling material for pathological diagnosis |
CN114945322A (en) * | 2019-11-13 | 2022-08-26 | 传感技术股份有限公司 | Identification of degraded Material |
CN116444509A (en) * | 2023-03-24 | 2023-07-18 | 湖南超亟检测技术有限责任公司 | DCM derivative near infrared fluorescent molecular probe for specifically detecting hypochlorous acid/hypochlorite ions and preparation method and application thereof |
-
2019
- 2019-12-20 CN CN201911322539.8A patent/CN113004216B/en active Active
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100081159A1 (en) * | 2008-09-26 | 2010-04-01 | Lebedeva Irina V | Profiling reactive oxygen, nitrogen and halogen species |
CN102382641A (en) * | 2011-09-22 | 2012-03-21 | 厦门大学 | Fluorescent probe for detecting hypochlorous acid and preparation method thereof |
CN103709122A (en) * | 2013-11-29 | 2014-04-09 | 四川大学 | Antitumor and antifungal compound for treatment |
US20160047816A1 (en) * | 2014-07-25 | 2016-02-18 | SeLux Diagnostics, Inc. | Assay methods involving dissociable nanoparticles |
CN105622632A (en) * | 2014-10-29 | 2016-06-01 | 浙江海森药业有限公司 | Quinolones compound and preparation method thereof |
CN109384719A (en) * | 2017-08-10 | 2019-02-26 | 湖南超亟化学科技有限公司 | A kind of preparation and application detecting formaldehyde fluorescent molecular probe, synthetic method and test paper |
CN108148055A (en) * | 2018-02-06 | 2018-06-12 | 陕西师范大学 | A kind of D- π-A types organic fluorescence materials and preparation method based on naphthalene |
WO2020037856A1 (en) * | 2018-08-20 | 2020-02-27 | 武汉华星光电半导体显示技术有限公司 | Thermally activated delayed fluorescence material and synthesis method therefor |
CN108864350A (en) * | 2018-08-20 | 2018-11-23 | 武汉华星光电半导体显示技术有限公司 | Thermal activation delayed fluorescence material, synthetic method, OLED luminescent device, display device |
CN109593192A (en) * | 2018-12-05 | 2019-04-09 | 中国科学院长春应用化学研究所 | Polyarylether/poly arylidene thio-ester and its preparation method and application with thermal activation delayed fluorescence effect |
CN109942504A (en) * | 2019-03-25 | 2019-06-28 | 浙江师范大学 | It is a kind of to detect hypochlorous fluorescent probe molecule and preparation method thereof |
CN114945322A (en) * | 2019-11-13 | 2022-08-26 | 传感技术股份有限公司 | Identification of degraded Material |
CN113493564A (en) * | 2020-04-07 | 2021-10-12 | 中国科学院长春应用化学研究所 | Organic polymer luminescent material with D-sigma-A structure and preparation method and application thereof |
WO2021261398A1 (en) * | 2020-06-25 | 2021-12-30 | コニカミノルタ株式会社 | Light-emitting nanoparticles and light-emitting labeling material for pathological diagnosis |
CN113200935A (en) * | 2021-04-26 | 2021-08-03 | 威海海洋生物医药产业技术研究院有限公司 | Fluorescent probe for hypochlorous acid detection and preparation method thereof |
CN116444509A (en) * | 2023-03-24 | 2023-07-18 | 湖南超亟检测技术有限责任公司 | DCM derivative near infrared fluorescent molecular probe for specifically detecting hypochlorous acid/hypochlorite ions and preparation method and application thereof |
Non-Patent Citations (8)
Title |
---|
CHUNG-CHIEH LEE,等: "Synthesis and Properties of Oxygen-Linked N-Phenylcarbazole Dendrimers", MACROMOLECULES, vol. 45, no. 02, pages 751 * |
JESSICA WARD,等: "Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling", BIOCHEMISTRY ., vol. 52, no. 51, pages 9187 - 9201 * |
JIANBO WANG: "An aggregation-induced emission-based pH-sensitive fluorescent probe for intracellular acidity sensing", RSC ADVANCES, no. 06, pages 25416 - 25419 * |
刘敏;谭慧龙;刘治国;王维;曾文彬;: "基于小分子的锌离子荧光分子探针研究进展", 有机化学, no. 08, pages 75 - 87 * |
周明;刘治国;叶秋稷;曾文彬;: "MRI荧光双模态分子影像探针研究进展", 磁共振成像, no. 01, pages 78 - 82 * |
李海东;樊江莉;彭孝军;: "识别次氯酸的荧光探针", 化学进展, no. 01, pages 29 - 47 * |
申有名;杨玉芬;谷标;: "一种基于菲并咪唑的新型次氯酸荧光探针及细胞成像研究", 分析测试学报, no. 08, pages 32 - 37 * |
黄昆: "细胞器靶向探针合成及荧光成像研究", 中国博士学位论文全文数据库 基础科学辑, no. 01, pages 006 - 12 * |
Also Published As
Publication number | Publication date |
---|---|
CN113004216B (en) | 2023-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111205280B (en) | Ratio type fluorescent probe for detecting hypochlorous acid and preparation method and application thereof | |
CN106632363B (en) | A kind of Mitochondrially targeted Ratio-type hypochlorous acid fluorescence probe and its application | |
CN111423423B (en) | Application of ratiometric fluorescent probe in detecting peroxynitrite anion | |
CN110563689B (en) | Long-wavelength emission fluorescent probe for specifically detecting cysteine in living cells and preparation method and application thereof | |
EP3078666B1 (en) | Boron-dipyrromethene fluorescence probes and manufacturing method and use thereof | |
CN109232626B (en) | SO based on difluoro boro coumarin2Ratiometric fluorescent probes | |
CN108169189B (en) | Ratiometric fluorescent probe responding to sulfur dioxide/sulfite (hydrogen) salt | |
CN110156839B (en) | Mitochondrial-targeted hypochlorite two-photon fluorescence probe and preparation method and application thereof | |
CN114181204B (en) | Near infrared fluorescent probe for detecting viscosity and preparation and application thereof | |
CN113004258B (en) | Preparation method and application of hydrogen sulfide ratio type fluorescent molecular probe based on ESIPT effect | |
CN106810561A (en) | A kind of lysosome targeting hypochlorous acid ratio fluorescent probe and preparation method and application | |
CN110818734A (en) | Fluorescent probe with double-ratio recognition function for hydrogen peroxide and hypochlorous acid | |
CN111689938A (en) | Preparation method of high-selectivity hypochlorous acid fluorescent probe | |
CN110878085B (en) | Rapid high-selectivity hypobromous acid fluorescent probe, preparation method and application | |
CN114105927B (en) | Construction of benzopyran nitrile fluorescent molecular probe and in-vitro diagnosis application thereof | |
CN111518066B (en) | Bifunctional fluorescent probe for identifying hypochlorite and bisulfite and preparation method and application thereof | |
CN111778014A (en) | Beta-galactosidase near-infrared fluorescent probe and preparation method and application thereof | |
CN109608495B (en) | Compound for detecting HNO and preparation method and application thereof | |
CN115232152B (en) | Fluorescent probe for detecting hypochlorous acid and preparation method and application thereof | |
CN113004216B (en) | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe | |
CN116375692A (en) | Near infrared fluorescent molecular probe for detecting cysteine, preparation method and kit thereof | |
CN109705055B (en) | Benzothiazole compound, preparation method thereof and application of benzothiazole compound as hypobromous acid probe | |
CN107698600B (en) | PH-responsive fluorescent sensing material based on rhodamine B and cyano diphenol and preparation method and application thereof | |
CN113004310B (en) | Preparation method and application of hydrogen peroxide ratio type fluorescent molecular probe based on DCPO parent nucleus | |
Nakahara et al. | Fluorophotometric determination of hydrogen peroxide and other reactive oxygen species with fluorescein hydrazide (FH) and its crystal structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211014 Address after: 410205 room 901, building 4, haipingyuan Park, No. 229, Guyuan Road, high tech Development Zone, Changsha, Hunan Applicant after: Hunan Chaoji Testing Technology Co.,Ltd. Address before: 410205 building C11, jinruilugu Science Park, 28 Lutian Road, high tech Development Zone, Changsha City, Hunan Province Applicant before: HUNAN CHAOJI CHEMICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |